BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37328410)

  • 1. Deficiency of adenosine deaminase 2 (DADA2): Review.
    Sharma V; Deo P; Sharma A
    Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101844. PubMed ID: 37328410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.
    Pinto B; Deo P; Sharma S; Syal A; Sharma A
    Clin Rheumatol; 2021 Oct; 40(10):3883-3896. PubMed ID: 33791889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment.
    Grim A; Veiga KR; Saad N
    Rheum Dis Clin North Am; 2023 Nov; 49(4):773-787. PubMed ID: 37821195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
    Gibson KM; Morishita KA; Dancey P; Moorehead P; Drögemöller B; Han X; Graham J; Hancock REW; Foell D; Benseler S; Luqmani R; Yeung RSM; Shenoi S; Bohm M; Rosenberg AM; Ross CJ; Cabral DA; Brown KL;
    Arthritis Rheumatol; 2019 Oct; 71(10):1747-1755. PubMed ID: 31008556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
    Meyts I; Aksentijevich I
    J Clin Immunol; 2018 Jul; 38(5):569-578. PubMed ID: 29951947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
    Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
    J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of ADA2 deficient polyarteritis nodosa.
    Human A; Pagnoux C
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():69-77. PubMed ID: 29624883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.
    Hashem H; Kelly SJ; Ganson NJ; Hershfield MS
    Curr Rheumatol Rep; 2017 Oct; 19(11):70. PubMed ID: 28983775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2.
    Hashem H; Kumar AR; Müller I; Babor F; Bredius R; Dalal J; Hsu AP; Holland SM; Hickstein DD; Jolles S; Krance R; Sasa G; Taskinen M; Koskenvuo M; Saarela J; van Montfrans J; Wilson K; Bosch B; Moens L; Hershfield M; Meyts I;
    Blood; 2017 Dec; 130(24):2682-2688. PubMed ID: 28974505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult-onset deficiency of adenosine deaminase 2-a case report and literature review.
    Zhang B; Sun Y; Xu N; Wang W; Huang X; Chen J; Shen M; Wang R; Zeng X; Zhang X
    Clin Rheumatol; 2021 Oct; 40(10):4325-4339. PubMed ID: 33638065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case with febrile attacks and vasculopathy associated with ADA2 and MEFV pathogenic variants.
    Parlar K; Tahir Turanli E; Nuhoglu Kantarci E; Hacioglu A; Kirectepe Aydin A; Ayla AY; Voyvoda U; Ozdogan H; Ugurlu S
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):121-124. PubMed ID: 37542433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases of ADA2 deficiency presenting as childhood polyarteritis nodosa: novel ADA2 variant, atypical CNS manifestations, and literature review.
    Ganhão S; Loureiro GB; Oliveira DR; Dos-Reis-Maia R; Aguiar F; Quental R; Moura C; Barreira JL; Rodrigues M; Brito I
    Clin Rheumatol; 2020 Dec; 39(12):3853-3860. PubMed ID: 32535845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monogenic polyarteritis: the lesson of ADA2 deficiency.
    Caorsi R; Penco F; Schena F; Gattorno M
    Pediatr Rheumatol Online J; 2016 Sep; 14(1):51. PubMed ID: 27609179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).
    Lee PY; Kellner ES; Huang Y; Furutani E; Huang Z; Bainter W; Alosaimi MF; Stafstrom K; Platt CD; Stauber T; Raz S; Tirosh I; Weiss A; Jordan MB; Krupski C; Eleftheriou D; Brogan P; Sobh A; Baz Z; Lefranc G; Irani C; Kilic SS; El-Owaidy R; Lokeshwar MR; Pimpale P; Khubchandani R; Chambers EP; Chou J; Geha RS; Nigrovic PA; Zhou Q
    J Allergy Clin Immunol; 2020 Jun; 145(6):1664-1672.e10. PubMed ID: 31945408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-α.
    Sahin S; Adrovic A; Barut K; Baran S; Tahir Turanli E; Canpolat N; Kizilkilic O; Ozkaya O; Kasapcopur O
    Paediatr Int Child Health; 2020 Feb; 40(1):65-68. PubMed ID: 30642227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation of children with Deficiency of Adenosine deaminase 2: A case series.
    Kisla Ekinci RM; Anlas O; Ozalp O
    Eur J Med Genet; 2022 Aug; 65(8):104555. PubMed ID: 35777620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency.
    Barzaghi F; Cicalese MP; Zoccolillo M; Brigida I; Barcella M; Merelli I; Sartirana C; Zanussi M; Calbi V; Bernardo ME; Tucci F; Migliavacca M; Giglio F; Doglio M; Canarutto D; Ferrua F; Consiglieri G; Prunotto G; Saettini F; Bonanomi S; Rovere-Querini P; Di Colo G; Jofra T; Fousteri G; Penco F; Gattorno M; Hershfield MS; Bongiovanni L; Ponzoni M; Marktel S; Milani R; Peccatori J; Ciceri F; Mortellaro A; Aiuti A
    Front Immunol; 2022; 13():910021. PubMed ID: 36248833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.
    Navon Elkan P; Pierce SB; Segel R; Walsh T; Barash J; Padeh S; Zlotogorski A; Berkun Y; Press JJ; Mukamel M; Voth I; Hashkes PJ; Harel L; Hoffer V; Ling E; Yalcinkaya F; Kasapcopur O; Lee MK; Klevit RE; Renbaum P; Weinberg-Shukron A; Sener EF; Schormair B; Zeligson S; Marek-Yagel D; Strom TM; Shohat M; Singer A; Rubinow A; Pras E; Winkelmann J; Tekin M; Anikster Y; King MC; Levy-Lahad E
    N Engl J Med; 2014 Mar; 370(10):921-31. PubMed ID: 24552285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2).
    Lee PY; Aksentijevich I; Zhou Q
    Semin Immunopathol; 2022 May; 44(3):269-280. PubMed ID: 35178658
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.